6533b7dafe1ef96bd126f594
RESEARCH PRODUCT
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP).
Massimiliano RuscicaPeter E. PensonNicola FerriCesare R. SirtoriMatteo PirroG.b. John ManciniNaveed SattarPeter P. TothAmirhossein SahebkarCarl J. LavieNathan D. WongMaciej BanachJulio AcostaMutaz Al-khnifsawiFahad AlnouriFahma AmarAtanas G. AtanasovGani BajraktariMaciej BanachSonu BhaskarBojko BjelakovicEric BruckertRichard CeskaArrigo F.g. CiceroXavier ColletOlivier DescampsDragan DjuricRonen DurstMarat V. EzhovZlatko FrasDan GaitaAdrian V. HernandezSteven R. JonesJacek JozwiakNona KakauridzeAmani KallelNiki KatsikiAmit KheraKaram KostnerRaimondas KubiliusGustavs LatkovskisG.b. John ManciniA. David MaraisSeth S. MartinJulio Acosta MartinezMohsen MazidiDimitri P. MikhailidisErkin M. MirrakhimovAndre R. MiserezOlena MitchenkoNatalya P. MitkovskayaPatrick M. MoriartySeyed Mohammad NabaviDevaki NairDemosthenes B. PanagiotakosGyörgy ParaghDaniel PellaPeter E. PensonZaneta PetrulionieneMatteo PirroArman PostadzhiyanRaman PuriAshraf RedaŽEljko ReinerDina RadenkovicMichał RakowskiJemaa RiadhDimitri RichterManfredi RizzoMassimiliano RuscicaAmirhossein SahebkarNaveed SattarMaria-corina SerbanAbdulla M.a. ShehabAleksandr B. ShekCesare R. SirtoriClaudia StefanuttiTomasz TomasikPeter P. TothMargus ViigimaaPedro ValdivielsoDragos VinereanuBranislav VohnoutStephan Von HaehlingMichal VrablikNathan D. WongHung-i YehJiang ZhishengAndreas Zirliksubject
RMArterial diseaseAnti-Inflammatory AgentsInflammationDiseaseC-reactive protein ; cardiovascular disease ; inflammation ; nutraceuticals ; omega-3 ; position paper ; red-yeast rice030204 cardiovascular system & hematologyBioinformaticsSystemic inflammationC-reactive protein03 medical and health sciences0302 clinical medicineNutraceuticalMedicineHumansPosition paper030212 general & internal medicineUncategorizedOmega-3InflammationbiologyC-reactive protein; Cardiovascular disease; Inflammation; Nutraceuticals; Omega-3; Position paper; Red-yeast rice; Anti-Inflammatory Agents; Biomarkers; Cardiovascular Diseases; Humans; Inflammation; Lipids; Dietary SupplementsVascular inflammationbusiness.industryC-reactive proteinC-reactive protein Cardiovascular disease Inflammation Nutraceuticals Omega-3 Position paper Red-yeast rice Anti-Inflammatory Agents Biomarkers Cardiovascular Diseases Humans Inflammation Lipids Dietary SupplementsCardiovascular diseaseRed-yeast riceLipidsCardiovascular DiseasesDietary Supplementsbiology.proteinPosition paperNutraceuticalsNutraceuticalmedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersdescription
Inflammation is a marker of arterial disease stemming from cholesterol-dependent to -independent molecular mechanisms. In recent years, the role of inflammation in atherogenesis has been underpinned by pharmacological approaches targeting systemic inflammation that have led to a significant reduction in cardiovascular disease (CVD) risk. Although the use of nutraceuticals to prevent CVD has largely focused on lipid-lowering (e.g, red-yeast rice and omega-3 fatty acids), there is growing interest and need, especially now in the time of coronavirus pandemic, in the use of nutraceuticals to reduce inflammatory markers, and potentially the inflammatory CVD burden, however, there is still not enough evidence to confirm this. Indeed, diet is an important lifestyle determinant of health and can influence both systemic and vascular inflammation, to varying extents, according to the individual nutraceutical constituents. Thus, the aim of this Position Paper is to provide the first attempt at recommendations on the use of nutraceuticals with effective anti-inflammatory properties.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-01-01 | Progress in cardiovascular diseases |